Left Ventricular and Endothelial Function in Preeclampsia

This study has been completed.
Sponsor:
Collaborator:
The Royal Norwegian Ministry of Health
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00201500
First received: September 16, 2005
Last updated: August 23, 2010
Last verified: August 2010
  Purpose

The purpose of this study is (1) to examine whether the left ventricular function is impaired in women with preeclampsia relative to healthy pregnant controls, (2) to examine whether the endothelial function is impaired in women with preeclampsia relative to healthy pregnant controls, and (3) to examine whether there is a post partum impairment in left ventricular and endothelial function.


Condition Phase
Preeclampsia
Phase 1
Phase 2

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Left Ventricular and Endothelial Function in Preeclampsia, a Case Control Study

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Biospecimen Retention:   Samples With DNA

Blood samples


Enrollment: 50
Study Start Date: October 2004
Study Completion Date: March 2006
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Women with preeclampsia and women with normotensive pregnancies.

Criteria

Inclusion Criteria:

  • >18 years of age
  • Case: Clinical diagnosis of preeclampsia,
  • Control: Systolic BP <140 mmHg and diastolic BP <90 mmHg

Exclusion Criteria:

  • Known hypertension or other cardiovascular disease
  • Diabetes/gestational diabetes
  • Multiple gestation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00201500

Locations
Norway
NTNU
Trondheim, Norway, N-7491
Sponsors and Collaborators
Norwegian University of Science and Technology
The Royal Norwegian Ministry of Health
Investigators
Study Chair: Stig A Slørdahl, Professor Norwegian University of Science and Technology
  More Information

No publications provided

Responsible Party: Eva Veslemøy Tyldum, Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00201500     History of Changes
Other Study ID Numbers: PEETLV
Study First Received: September 16, 2005
Last Updated: August 23, 2010
Health Authority: Norway: Norwegian Social Science Data Services

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on October 21, 2014